Arteriosclerosis and Thrombosis, Vol 11, 1330-1348, Copyright © 1991 by American Heart Association
ARTICLES |
J Kaprio, RE Ferrell, BA Kottke, MI Kamboh and CF Sing
Department of Human Genetics, University of Michigan Medical School, Ann Arbor 48109-0618.
The impact of the common alleles at structural loci coding for apolipoprotein (apos) A-IV, E, and H on 12 quantitative risk factors for cardiovascular disease (apos A-I, A-II, B, C-II, C-III, and E; total cholesterol; triglycerides; high density lipoprotein cholesterol; systolic blood pressure; diastolic blood pressure; and red blood cell sodium-lithium countertransport) was estimated in 453 unrelated individuals (227 men and 226 women) aged 26-63 years from the Rochester Family Heart Study, who were not using medications affecting lipid levels or blood pressure. Each risk factor was adjusted for concomitants (assay date, age, age, squared, height, weight and smoking status) before the genotypic effects on mean levels and variances were estimated. Allele frequencies were the same in men and women and were similar to those observed in other studies of US Caucasians. There were very different gender-specific estimates of the relative contribution of concomitants, measured genetic effects, and residual unexplained effects to the interindividual variation of particular traits. Allelic variation in apo E had effects on the greatest number of traits, namely apo E, apo B, apo C-II, and total cholesterol. An effect on triglycerides was dependent on the inclusion of hypertriglyceridemic subjects. Allelic effects of apo A-IV and apo H were much less than those estimated for the apo E polymorphism. A possible role for apo H in high density lipoprotein metabolism is suggested. This study indicates that variation in many genes may influence variation in a particular trait and that a particular gene may have pleiotropic effects on several traits.
This article has been cited by other articles:
![]() |
G. Kolovou, D. Damaskos, K. Anagnostopoulou, and D. V. Cokkinos Apolipoprotein E Gene Polymorphism and Gender Ann. Clin. Lab. Sci., January 1, 2009; 39(2): 120 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Leduc, L. C. Shimmin, K. L. E. Klos, C. Hanis, E. Boerwinkle, and J. E. Hixson Comprehensive evaluation of apolipoprotein H gene (APOH) variation identifies novel associations with measures of lipid metabolism in GENOA J. Lipid Res., December 1, 2008; 49(12): 2648 - 2656. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. E. Klos, E. Boerwinkle, R. E. Ferrell, S. T. Turner, and A. C. Morrison ESR1 polymorphism is associated with plasma lipid and apolipoprotein levels in Caucasians of the Rochester Family Heart Study J. Lipid Res., August 1, 2008; 49(8): 1701 - 1706. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Stengard, S. L. R. Kardia, S. C. Hamon, R. Frikke-Schmidt, A. Tybjaerg-Hansen, V. Salomaa, E. Boerwinkle, and C. F. Sing Contribution of regulatory and structural variations in APOE to predicting dyslipidemia J. Lipid Res., February 1, 2006; 47(2): 318 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Heyer, D. A. Wilson, D. H. Sahlein, J. Mocco, S. C. Williams, R. Sciacca, A. Rampersad, R. J. Komotar, J. Zurica, A. Benvenisty, et al. APOE-{varepsilon}4 predisposes to cognitive dysfunction following uncomplicated carotid endarterectomy Neurology, December 13, 2005; 65(11): 1759 - 1763. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. E. Klos, S. Hamon, A. G. Clark, E. Boerwinkle, K. Liu, and C. F. Sing APOA5 polymorphisms influence plasma triglycerides in young, healthy African Americans and whites of the CARDIA Study J. Lipid Res., March 1, 2005; 46(3): 564 - 571. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Templeton, T. Maxwell, D. Posada, J. H. Stengard, E. Boerwinkle, and C. F. Sing Tree Scanning: A Method for Using Haplotype Trees in Phenotype/Genotype Association Studies Genetics, January 1, 2005; 169(1): 441 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lussier-Cacan, A. Bolduc, M. Xhignesse, T. Niyonsenga, and C. F. Sing Impact of Alcohol Intake on Measures of Lipid Metabolism Depends on Context Defined by Gender, Body Mass Index, Cigarette Smoking, and Apolipoprotein E Genotype Arterioscler Thromb Vasc Biol, May 1, 2002; 22(5): 824 - 831. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Klos, S. L. R. Kardia, R. E. Ferrell, S. T. Turner, E. Boerwinkle, and C. F. Sing Genome-Wide Linkage Analysis Reveals Evidence of Multiple Regions That Influence Variation in Plasma Lipid and Apolipoprotein Levels Associated With Risk of Coronary Heart Disease Arterioscler Thromb Vasc Biol, June 1, 2001; 21(6): 971 - 978. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Frikke-Schmidt, B. G. Nordestgaard, B. Agerholm-Larsen, P. Schnohr, and A. Tybjærg-Hansen Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype J. Lipid Res., November 1, 2000; 41(11): 1812 - 1822. [Abstract] [Full Text] |
||||
![]() |
R. Frikke-Schmidt, A. Tybjaerg-Hansen, R. Steffensen, G. Jensen, and B.o. G. Nordestgaard Apolipoprotein E genotype: epsilon32 women are protected while epsilon43 and epsilon44 men are susceptible to ischemic heart disease: The Copenhagen City Heart Study J. Am. Coll. Cardiol., April 1, 2000; 35(5): 1192 - 1199. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Fisher, H. Burke, V. Nicaud, C. Ehnholm, and S. E. Humphries Effect of variation in the apo A-IV gene on body mass index and fasting and postprandial lipids in the European Atherosclerosis Research Study II J. Lipid Res., February 1, 1999; 40(2): 287 - 294. [Abstract] [Full Text] |
||||
![]() |
S. L. R. Kardia, M. B. Haviland, R. E. Ferrell, and C. F. Sing The Relationship Between Risk Factor Levels and Presence of Coronary Artery Calcification is Dependent on Apolipoprotein E Genotype Arterioscler Thromb Vasc Biol, February 1, 1999; 19(2): 427 - 435. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Tardiff, M. F. Newman, A. M. Saunders, W. J. Strittmatter, J. A. Blumenthal, W. D. White, N. D. Croughwell, R. D. Davis Jr, A. D. Roses, and J. G. Reves Preliminary Report of a Genetic Basis for Cognitive Decline After Cardiac Operations Ann. Thorac. Surg., September 1, 1997; 64(3): 715 - 720. [Abstract] [Full Text] |
||||
![]() |
S. Kataoka, D. C. Robbins, L. D. Cowan, O. Go, J. L. Yeh, R. B. Devereux, R. R. Fabsitz, E. T. Lee, T. K. Welty, and B. V. Howard Apolipoprotein E Polymorphism in American Indians and Its Relation to Plasma Lipoproteins and Diabetes: The Strong Heart Study Arterioscler Thromb Vasc Biol, August 1, 1996; 16(8): 918 - 925. [Abstract] [Full Text] |
||||
![]() |
M. C. Mahaney, J. Blangero, D. L. Rainwater, A. G. Comuzzie, J. L. VandeBerg, M. P. Stern, J. W. MacCluer, and J. E. Hixson A Major Locus Influencing Plasma High-Density Lipoprotein Cholesterol Levels in the San Antonio Family Heart Study : Segregation and Linkage Analyses Arterioscler Thromb Vasc Biol, October 1, 1995; 15(10): 1730 - 1739. [Abstract] [Full Text] |
||||
![]() |
J. H. Stengard, K. E. Zerba, J. Pekkanen, C. Ehnholm, A. Nissinen, and C. F. Sing Apolipoprotein E Polymorphism Predicts Death From Coronary Heart Disease in a Longitudinal Study of Elderly Finnish Men Circulation, January 15, 1995; 91(2): 265 - 269. [Abstract] [Full Text] |
||||
![]() |
R. J. McCombs, D. E. Marcadis, J. Ellis, and R. B. Weinberg Attenuated Hypercholesterolemic Response to a High-Cholesterol Diet in Subjects Heterozygous for the Apolipoprotein A-IV-2 Allele N. Engl. J. Med., September 15, 1994; 331(11): 706 - 710. [Abstract] [Full Text] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1991 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |